youtube_live
Q3 2026 earnings • released • EPS beat +2.32% • Revenue miss -0.16%
See resultschevron_right
ALC:NYSE
Alcon AG
$72.47
arrow_upward
+0.01%(+0.010) 1D
Nov 12, 10:47:41 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$73.06
High
$73.96
Low
$72.24
Mkt. cap
30.51B
Avg. vol.
2.08M
Volume
632.00K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$73.06
High
$73.96
Low
$72.24
Mkt. cap
30.51B
Avg. vol.
2.08M
Volume
632.00K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
Investing.com
·
24 minutes ago
Bernstein cuts Alcon stock price target on Q3 revenue miss
Investing.com
·
2 hours ago
Jefferies reiterates Alcon stock Buy rating, lowers estimates
Benzinga
·
3 hours ago
NVIDIA To $186? Here Are 10 Top Analyst Forecasts For Thursday
Yahoo Finance
·
17 hours ago
Alcon: 3 Key Takeaways for Long-Term Investors
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com